AEON.WS
AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share
AEON.WS
AEON.WS
Delisted
AEON.WS was delisted on the 26th of April, 2024.
49 hedge funds and large institutions have $2.87M invested in AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
-3
Holders Change %
-5.77%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
7
Reduced
2
Closed
10
Calls
$352K
Puts
–
Net Calls
+$352K
Net Calls Change
-$662K
Top Buyers
1 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$16.4K |
2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$7.38K |
3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$4.54K |
4 |
LIM
Longfellow Investment Management
Boston,
Massachusetts
|
+$3.57K |
5 |
SG
StoneX Group
New York
|
+$2.78K |